Loading...
Found 389 oncology trials
A listing of oncology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
Please refer to Section 5 (Research question and objectives) of the full study protocol.
The purpose of this study is to improve our understanding of graft-versus-host disease (GVHD) which is a complication that can occur after a bone marrow transplant. Investigators at Mount Sinai and other BMT centers around the world have formed a collaboration to share and study clinical data and blood samples …
This study investigates the impact of assessing physiologic age in patients newly diagnosed with acute myeloid leukemia (AML) who are 50 years or older. The purpose is to understand how evaluating patients' overall health rather than just their chronological age can affect treatment outcomes such as toxicity, early mortality, remission …
This study investigates Von Hippel Lindau (vHL) disease, focusing on data collection regarding disease progression, surgeries or therapies patients have undergone, and their quality of life. The study also aims to understand how different genetic mutations in vHL are linked to the development of lesions and response to treatments.Participants will …
This study investigates the safety and effectiveness of an investigational medication in patients with relapsed or refractory leukemias, including those with specific genetic changes such as MLL/KMT2A gene rearrangement or NPM1 mutation. The study is divided into two phases: Phase 1 aims to find the best dose of the investigational …
This study investigates the effects of different maintenance therapies in people with newly diagnosed multiple myeloma. The purpose of this study is to compare the investigational medication teclistamab in combination with lenalidomide, teclistamab alone, and lenalidomide alone in maintaining health after a stem cell transplant.Participants will be randomly assigned to …
This study investigates the long-term safety and effects of an investigational medication in people with Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), or Non-Hodgkin Lymphoma (NHL) who have already received treatment. The purpose of this study is to provide participants from a previous study with the opportunity to continue …
See Section 1 of the full protocol See Section 1.1 of the full protocol See Section 1.2 of the full protocol
The purpose of this study is to assess the retreatment of chronic lymphocytic leukemia (CLL) using a combination of investigational medications. Participants in this study have previously been treated with a specific therapy involving an anti-CD20 antibody and are now being evaluated for retreatment. The study will look into how …
The purpose of this study is to investigate the long-term safety of an investigational medication after participants have completed earlier clinical studies. This study will include individuals from previous studies, called originator studies, and will allow them to continue receiving treatment or follow-up visits. The study will use a master …
Please choose between Voice or SMS based delivery of verification code
or